Enter your keyword

Efficiently Creating Value with Innovative Science

Press Release

Jan 03, 2018
Mateon Therapeutics to Present at the 2018 Biotech Showcase

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today announced that it will present a company overview at the 2018 Biotech Showcase on Tuesday, January 9, 2018 at 4:00 p.m. pacific time in San Francisco.

To listen to a live webcast of the presentation, please visit the Company's website, www.mateon.com. Under the "Investors & News" tab, select the link to "Events & Presentations." A replay of the webcast will be available at this same location for a period of time following the conclusion of the live event.

About Mateon
Mateon Therapeutics, Inc. is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, with programs in acute myeloid leukemia and immuno-oncology. Mateon is committed to leveraging its product development expertise and intellectual property to bring improved and medically necessary new therapies to cancer patients worldwide.

CONTACTS 

Investors:
Mateon Therapeutics, Inc.
Matthew M. Loar
ir@mateon.com
650-635-7000

Primary Logo

Source: Mateon Therapeutics

News Provided by Acquire Media